BR9611173A - Método para mobilizar células hematopéticas ancestrais - Google Patents
Método para mobilizar células hematopéticas ancestraisInfo
- Publication number
- BR9611173A BR9611173A BR9611173A BR9611173A BR9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A
- Authority
- BR
- Brazil
- Prior art keywords
- hematopathic
- mobilizing
- ancestral
- cells
- mobilizing ancestral
- Prior art date
Links
- 230000001483 mobilizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54726295A | 1995-10-24 | 1995-10-24 | |
| PCT/US1996/017074 WO1997015595A1 (en) | 1995-10-24 | 1996-10-24 | Method of mobilizing hematopoietic stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9611173A true BR9611173A (pt) | 1999-03-30 |
Family
ID=24183989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9611173A BR9611173A (pt) | 1995-10-24 | 1996-10-24 | Método para mobilizar células hematopéticas ancestrais |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0866806A4 (es) |
| JP (1) | JPH11512747A (es) |
| KR (1) | KR19990066997A (es) |
| AR (1) | AR004093A1 (es) |
| AU (1) | AU712235B2 (es) |
| BR (1) | BR9611173A (es) |
| CZ (1) | CZ120298A3 (es) |
| HU (1) | HUP9802531A3 (es) |
| NO (1) | NO981818L (es) |
| NZ (1) | NZ321789A (es) |
| PL (1) | PL326364A1 (es) |
| TR (1) | TR199800742T2 (es) |
| WO (1) | WO1997015595A1 (es) |
| ZA (1) | ZA968896B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174995B1 (en) | 1994-08-23 | 2001-01-16 | Haodong Li | Human chemokines, CKβ4 and CKβ10/MCP-4 |
| US6391589B1 (en) | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
| US6458349B1 (en) | 1995-06-02 | 2002-10-01 | Human Genome Sciences, Inc. | Chemokine β-4 polypeptides |
| US6042821A (en) * | 1995-11-21 | 2000-03-28 | Smithkline Beecham Corporation | Method of treating sepsis with chemokines |
| US6290948B1 (en) * | 1996-05-14 | 2001-09-18 | Smithkline Beecham Corporation | Method of treating sepsis and ARDS using chamohine beta-10 |
| ATE293987T1 (de) * | 1997-11-26 | 2005-05-15 | Smithkline Beecham Corp | Methode zur mobilisierung hematopoietischer stammzellen |
| CA2339900A1 (fr) * | 1999-06-08 | 2000-12-14 | Transgene S.A. | Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere |
| AU2002216749A1 (en) * | 2000-06-30 | 2002-01-14 | Smithkline Beecham Corporation | Chemokine conjugates |
| JP3563366B2 (ja) | 2001-05-07 | 2004-09-08 | 独立行政法人 科学技術振興機構 | 蛋白質高次構造に対してアンフォールド活性を有する蛋白質多量体 |
| IL146970A0 (en) * | 2001-12-06 | 2002-08-14 | Yeda Res & Dev | Migration of haematopoietic stem cells and progenitor cells to the liver |
| US7375192B2 (en) | 2002-05-01 | 2008-05-20 | Human Genome Sciences, Inc. | Antibodies that specifically bind to chemokine beta-4 |
| TWI589587B (zh) | 2010-11-19 | 2017-07-01 | 衛材R&D企管股份有限公司 | 中和性抗-ccl20抗體 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1378522A3 (en) * | 1993-06-08 | 2004-02-04 | SmithKline Beecham Corporation | Methods of enhancing bioactivity of chemokines |
| GB9426012D0 (en) * | 1994-12-22 | 1995-02-22 | British Biotech Pharm | Mobilisation of haematopoietic cells |
| GB9517014D0 (en) * | 1995-08-19 | 1995-10-25 | British Biotech Pharm | Haematopoietic recovery |
-
1996
- 1996-10-23 ZA ZA968896A patent/ZA968896B/xx unknown
- 1996-10-24 KR KR1019980702932A patent/KR19990066997A/ko not_active Withdrawn
- 1996-10-24 BR BR9611173A patent/BR9611173A/pt not_active Application Discontinuation
- 1996-10-24 HU HU9802531A patent/HUP9802531A3/hu unknown
- 1996-10-24 EP EP96937739A patent/EP0866806A4/en not_active Withdrawn
- 1996-10-24 AU AU75209/96A patent/AU712235B2/en not_active Ceased
- 1996-10-24 TR TR1998/00742T patent/TR199800742T2/xx unknown
- 1996-10-24 PL PL96326364A patent/PL326364A1/xx unknown
- 1996-10-24 CZ CZ981202A patent/CZ120298A3/cs unknown
- 1996-10-24 JP JP9516787A patent/JPH11512747A/ja active Pending
- 1996-10-24 AR ARP960104890A patent/AR004093A1/es unknown
- 1996-10-24 NZ NZ321789A patent/NZ321789A/en unknown
- 1996-10-24 WO PCT/US1996/017074 patent/WO1997015595A1/en not_active Ceased
-
1998
- 1998-04-23 NO NO981818A patent/NO981818L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9802531A2 (hu) | 1999-02-01 |
| TR199800742T2 (xx) | 1998-08-21 |
| AU712235B2 (en) | 1999-11-04 |
| EP0866806A1 (en) | 1998-09-30 |
| NZ321789A (en) | 2000-07-28 |
| AU7520996A (en) | 1997-05-15 |
| ZA968896B (en) | 1997-04-24 |
| PL326364A1 (en) | 1998-09-14 |
| EP0866806A4 (en) | 2002-01-09 |
| JPH11512747A (ja) | 1999-11-02 |
| HUP9802531A3 (en) | 2001-08-28 |
| MX9803217A (es) | 1998-09-30 |
| NO981818L (no) | 1998-06-17 |
| WO1997015595A1 (en) | 1997-05-01 |
| KR19990066997A (ko) | 1999-08-16 |
| NO981818D0 (no) | 1998-04-23 |
| AR004093A1 (es) | 1998-09-30 |
| CZ120298A3 (cs) | 1998-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972699A7 (fi) | Menetelmä pintojen funktionalisoimiseksi | |
| DE69617372D1 (de) | Datenaufzeichnungs-/-wiedergabeverfahren | |
| BR9508190A (pt) | Método para fabricar prepreg | |
| FI962069L (fi) | Menetelmä karpolaktaamin valmistamiseksi | |
| FI972764A7 (fi) | Menetelmä liuosten muodostamiseksi | |
| DE69523060D1 (de) | Luziferase-markierungsmethode | |
| KR970001365A (ko) | 알킬하이드로겐클로로실란의 제조방법 | |
| LV11745A (lv) | Metode nepartrauktai misas varisanai | |
| NO970726D0 (no) | Test-fremgangsmåte | |
| FI964005A7 (fi) | Menetelmä otsonin konsentroimiseksi | |
| FI955855L (fi) | Menetelmä ksylitolin tuottamiseksi | |
| BR9611173A (pt) | Método para mobilizar células hematopéticas ancestrais | |
| FI955800L (fi) | Menetelmä aminoalkyyliganidiinien valmistamiseksi | |
| DE69507032D1 (de) | Chlorhydrin-verfahren | |
| MA24472A1 (fr) | Procede | |
| BR9408521A (pt) | Método para sintetizar gama-pironas | |
| FI960907L (fi) | Menetelmä kuivatustehon säätämiseksi | |
| BR9611040A (pt) | Método de fabrição para 1,1,1,3,3-pentaflúorpropano | |
| ID15862A (id) | Proses | |
| ID20955A (id) | Proses untuk memproduksi 7-oktan-1-al | |
| KR970006291A (ko) | 치환된 아미노카보닐트리아졸리논의 제조방법 | |
| FI955856A0 (fi) | Menetelmä sokereiden dekarbonyloimiseksi | |
| FI931051A7 (fi) | Kuvausmenetelmä | |
| FI953291A7 (fi) | Menetelmä meta- ja paraetyylifenolin erottamiseksi | |
| FI961467L (fi) | Sähkökemiallinen menetelmä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |